Transport evaluation of alendronate across Caco-2 cell monolayers

Pharmazie

Volumn 64, Issue 2, 2009, Pages 98-103

  Karamustafa, F ^a   Çelebi, Nevin ^a   Degim Z ^a   Unal N ^b  

^a GAZI UNIVERSITY   (Turkey)

^b Food and Mouth Diseases Institute   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CYCLODEXTRIN DERIVATIVE; DIMETHYL BETA CYCLODEXTRIN; TAUROCHOLIC ACID; UNCLASSIFIED DRUG; BETA CYCLODEXTRIN DERIVATIVE; BONE DENSITY CONSERVATION AGENT; EXCIPIENT; HEPTAKIS(2,6 O DIMETHYL)BETA CYCLODEXTRIN; HEPTAKIS(2,6-O-DIMETHYL)BETA-CYCLODEXTRIN; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ARTICLE; CELL MEMBRANE; CELL STRAIN CACO 2; CELL VIABILITY; DRUG ABSORPTION; DRUG PENETRATION; DRUG TRANSPORT; ELECTRIC RESISTANCE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MONOLAYER CULTURE; SERUM; ABSORPTION; ACTIVE TRANSPORT; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; DRUG EFFECT; IMPEDANCE;

ABSORPTION; ALENDRONATE; BETA-CYCLODEXTRINS; BIOLOGICAL TRANSPORT, ACTIVE; BONE DENSITY CONSERVATION AGENTS; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; ELECTRIC IMPEDANCE; EXCIPIENTS; HUMANS; TAUROCHOLIC ACID; TETRAZOLIUM SALTS; THIAZOLES;

EID: 65349096136     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.8201     Document Type: Article

References (37)

1. Abid-Essefi S, Baudrimont I, Hassen W, Ouanes Z, Mobio TA, Anane R, Creppy EE, Bacha H (2003) DNA fragmentation, apoptosis and cell cycle arrest induced by zearalenone in cultured dok, vero and Caco-2 cells: prevention by vitamin E. Toxicol 192: 137-248.
2. Anderberg EK, Nyström C, Artursson P (1992) Epithelial transport of drugs in cell culture. VII: effects of pharmaceutical surfactant excipients and bile acids of transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells. J Pharm Sci 81: 879-887.
3. Audus KL, Bartel RL, Hidalgo IJ, Borchardt RT (1990) The use of cultured epithelial and endothelial cells for drug transport and metabolism studies. Pharm Res 7: 435-449.
4. Bone HG, Adami S, Rizzoli R, Favus M, Ross PD, Santora A, Prahalada S, Daifotis A, Orloff J, Yates J (2000) Weekly administration of alendronate: rationale and plan for clinical assessment. Clin Ther 22 : 15-28.
5. Boulenc X, Breul T, Gautier JC, Saudemon P, Joyeux H, Roques C, Berger Y, Fabre G (1995a) Sodium lauryl sulphate increases tiludonate paracellular transport using human epithelial Caco-2 monolayers. Int J Pharm 123: 71-83.
6. Boulenc X, Roques C, Joyeux H, Berger Y, Fabre G (1995b) Bisphosphonates increase tight junction permeability in the human intestinal epithelial (Caco-2) model. Int J Pharm 123: 13-24.
7. Degim Z, Ünal N, Eşsiz D, Abbasoglu U (2004) The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer. Life Sci 75: 2819-2827.
8. De Marco J, Biffar SE, Reed DG, Brooks MA (1989) The determination of 4-amino-1-hydroxybutane-1,1-diphosphonic acid monosodium salt trihydrate in pharmaceutical dosage forms by high-performance liquid chromatography. J Pharm Biomed Anal 7: 1719-1727.
9. Fogh J, Fogh JM, Orfeo T (1977) One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59: 221-226.
10. Foss AC, Peppas NA (2004) Investigation of the cytotoxicity and insulin transport of acrylic-based copolymer protein delivery systems in contact with Caco-2 cultures. Eur J Pharm Biopharm 57: 447-455.
11. Francis RM (1997) Bisphosphonates in the treatment of osteoporosis in 1997: a review. Curr Ther Res 58: 656-678.
12. Gerloczy A, Hoshino T, Pitha J (1994) Safety of oral cyclodextrins: effects of hydroxypropyl cyclodextrins, cyclodextrin sulfates and cationic cyclodextrins on steroid balance in rats. J Pharm Sci 83: 193-196.
13. Gertz BJ, Holland SD, Kline WF, Matuszewski BK, Freeman A, Quan H, Lasseter KC, Mucklow JC, Porras AG (1995) Studies of the oral bioavailability of alendronate. Clin Pharmacol Ther 58: 288-298.
14. Greenwood R, Al-Achi A (1997) Human insulin diffusion profile through a layer of Caco-2 cells. Drug Dev Ind Pharm 23: 221-224.
15. Johansson F, Hjertberg E, Eirefelt S, Tronde A, Bengtsson UH (2002) Mechanisms for absorption enhancement of inhaled insulin by sodium taurocholate. Eur J Pharm Sci 17: 63-71.
16. Karamustafa F (2005) Development of a microemulsion formulation of alendronate and evaluation of its transport through Caco-2 cells. M. S. Thesis, Gazi University, Institute of Health Science, Ankara.
17. Karamustafa F, Çelebi N, Deǧim Z, Ünal N (2006a) The effect of dimethyl-β-cyclodextrin on transport of alendronate through human intestinal cell line, Caco-2. Proc 5th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, March 27-30; Geneva, Switzerland.
18. Karamustafa F, Deǧim Z, Çelebi N, Ünal N (2006 b) Transport of alendronate through human intestinal cell line, Caco-2, 33rd Annual Meeting & Exposition of the Controlled Release Society, July 22-26; Vienna, Austria.
19. Keenan J, Meleady P, Clynes M (1998) Serum-free media. In: Clynes M (ed.) Animal Cell Culture Techniques, Springer-Verlag, Berlin, pp. 54-66.
20. Lane ME, O'Driscoll CM, Corrigan OI (1996) The relationship between rat intestinal permeability and hydrophilic probe size. Pharm Res 13(10): 1554-1558.
21. Lin JH, Duggan DE, Chen IW, Ellsworth RL (1991) Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animals. Drug Metab Dispos 19(5): 926-932.
22. Lin JL, Chen IW, Deluna FA (1994) On the absorption of alendronate in rats. J Pharm Sci 83(12): 1741-1746.
23. Meaney CM, O'Driscoll CM (2000) A comparison of the permeation enhancement potential of simple bile salt and mixed bile salt: fatty acid micellar systems using the Caco-2 cell culture model. Int J Pharm 207: 21-30.
24. Menschutkin N (1865) Ueber die Einwirkung des Chloracetyls auf phosphorige Säure. Ann Chem Pharm 133: 317-320.
25. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
26. O'Reilly JR, Corrigan OL, O'Driscoll CM (1994) The effect of mixed micellar systems, bile salt/fatty acids, on the solubility and intestinal absorption of clofazimine (B 663) in the anaesthetised rat. Int J Pharm 109 : 147-154.
27. Palamakula A, Khan MA (2004) Evaluation of cytotoxicity of oils used in coenzyme Q10 self-emulsifying drug delivery systems (SEDDS). Int J Pharm 273: 63-73.
28. Poelma FGJ, Breas R, Tukker JJ (1990) Intestinal absorption of drugs. IV. the influence of taurocholate and L-cysteine on the barrier function of mucus. Int J Pharm 64: 161-169.
29. Raiman J, Törmälehto S, Yritys K, Junginger HE, Mönkkönen J (2003) Effects of various absorption enhancers on transport of clodronate through Caco-2 cells. Int J Pharm 261: 129-136.
30. Raiman J, Neimi R, Vepsäläinen J, Yritys K, Järvinen T, Mönkkönen J (2001) Effects of calcium and lipophilicity on transport of clodronate and its esters through Caco-2 cells. Int J Pharm 213: 135-142.
31. Rajewski RA, Stella VJ (1996) Pharmaceutical applications of cyclodextrins. 2. in vivo drug delivery. J Pharm Sci 85: 1142-1169.
32. Sakai M, Imai T, Ohtake H, Azuma H, Otagiri M (1998) Effects of absorption enhancers on cytoskeletal actin filaments in Caco-2 cell monolayers. Life Sci 63: 45-54.
33. Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Golub E, Rodan GA (1991) Bisphosphonate action, alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 88: 2095-2105.
34. Sharpe M, Noble S, Spencer CM (2001) Alendronate an update of its use in osteoporosis. Drugs 61: 999-1039.
35. Silano M, Vincentini O, Muzzarelli RAA, Muzzarelli C, De Vincenzi M (2004) Mp-chitosan protects Caco-2 cells from toxic gliadin peptides. Carbohydrate Polymers 58: 215-219.
36. Physicians' Desk Reference (2005) 59th ed. Thomson PDR, Montvale. Udata C, Patel J, Pal D, Hejchman E, Cushman M, Mitra AK (2003) Enhanced transport of a novel anti-hiv agent-cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers. Int J Pharm 250: 157-168.
37. Zhou S, Feng X, Kestell P, Paxton JW, Baguley BC, Chan E (2005) Transport of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid and its acyl glucuronide by human intestinal Caco-2 cells. Eur J Pharm Sci 24: 513-524.